A bilirubin-derived nanomedicine attenuates the pathological cascade of pulmonary fibrosis
Hyeongseop Keum, Do Hyeon Kim, Jinjoo Kim, Tae Woo Kim, Chang‐Hee Whang, Wonsik Jung, Sangyong Jon
Topics & Concepts
ARDSPulmonary fibrosisBleomycinMedicineFibrosisLungOxidative stressDiseaseImmune systemImmunologyPharmacologyPathologyInternal medicineChemotherapyInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisHeme Oxygenase-1 and Carbon MonoxideChronic Obstructive Pulmonary Disease (COPD) Research